• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酪胺、间羟胺和异丙肾上腺素在分离的嗜铬粒和空泡中的蓄积机制。

Mechanisms of accumulation of tyramine, metaraminol, and isoproterenol in isolated chromaffin granules and ghosts.

作者信息

Johnson R G, Carty S E, Hayflick S, Scarpa A

出版信息

Biochem Pharmacol. 1982 Mar 1;31(5):815-23. doi: 10.1016/0006-2952(82)90468-3.

DOI:10.1016/0006-2952(82)90468-3
PMID:7082350
Abstract

The effects of the transmembrane pH gradient (delta pH) and the transmembrane potential gradient (delta psi) on the uptake of several sympathomimetic amines were investigated, using bovine adrenal chromaffin granules isolated in isotonic sucrose. As previously described [R. Johnson and A. Scarpa, J. Biol. Chem. 254 3750 (1979)], freshly isolated chromaffin granules maintain an intragranular pH of 5.5 as measured by [14C] methylamine distribution and, in the presence of ATP, generate a delta psi of 80 mV, positive inside, as measured by [14C] methylamine distribution. When tyramine, metaraminol, and isoproterenol (1-50 mM) were added to well-buffered suspensions of granules at pH 7.0, a dose-related alkalinization of the granule interior was observed. Study of the time-resolved influx of the same amines labeled radiochemically (5-21 microM) revealed that all the amines were accumulated against an apparent concentration gradient. However, while accumulation of [14C] serotonin and [3H] isoproterenol was totally inhibited by reserpine, [14C] tryramine accumulation was inhibited by only 60% and [14C[ metaraminol uptake was unaffected. The ATP-dependent generation of a delta psi produced a stimulation of amine uptake in the order: serotonin greater than isoproterenol greater than tyramine; metaraminol accumulation was not enhanced by ATP addition. The relationship between the electrochemical proton gradient (delta micro H+) and the electrochemical gradient for each of the sympathomimetic amines (delta micro A) was investigated utilizing chromaffin ghosts devoid of endogenous matrix gradients or components. All amines were accumulated in the presence of delta pH alone. In the presence of delta psi alone, [14C] serotonin, (14C] tyramine, and [3H] isoproterenol were accumulated, but no [3H] metaraminol uptake was demonstrable. The results indicate that serotonin and isoproterenol accumulated in isolated chromaffin granules and ghosts via a reserpine-sensitive mechanism, driven by the magnitude of the electrochemical proton gradient. Conversely, metaraminol permeated the membrane of the chromaffin granule through the apolar lipid phase and distributed according to the delta pH alone. Tyramine uptake proceeded by both mechanisms. The implications of the mechanism of accumulation of these potent physiologic and pharmacologic agents for their in vivo action are discussed.

摘要

利用等渗蔗糖中分离出的牛肾上腺嗜铬颗粒,研究了跨膜pH梯度(δpH)和跨膜电位梯度(δψ)对几种拟交感神经胺摄取的影响。如先前所述[R. 约翰逊和A. 斯卡尔帕,《生物化学杂志》254, 3750 (1979)],通过[14C]甲胺分布测量,新鲜分离的嗜铬颗粒维持颗粒内pH为5.5,并且在ATP存在下,通过[14C]甲胺分布测量,产生80 mV的δψ,内部为正。当将酪胺、间羟胺和异丙肾上腺素(1 - 50 mM)添加到pH 7.0的颗粒缓冲良好的悬浮液中时,观察到颗粒内部呈剂量相关的碱化。对用放射化学标记(5 - 21 μM)的相同胺的时间分辨流入的研究表明,所有胺都逆着明显的浓度梯度积累。然而,虽然[14C]血清素和[3H]异丙肾上腺素的积累被利血平完全抑制,但[14C]酪胺的积累仅被抑制60%,[14C]间羟胺的摄取不受影响。ATP依赖性的δψ产生以血清素>异丙肾上腺素>酪胺的顺序刺激胺摄取;添加ATP并未增强间羟胺的积累。利用缺乏内源性基质梯度或成分的嗜铬颗粒空壳,研究了电化学质子梯度(δμH+)与每种拟交感神经胺的电化学梯度(δμA)之间的关系。仅在存在δpH时,所有胺都积累。仅在存在δψ时,[14C]血清素、[14C]酪胺和[3H]异丙肾上腺素积累,但未显示出[3H]间羟胺的摄取。结果表明,血清素和异丙肾上腺素通过利血平敏感机制在分离的嗜铬颗粒和颗粒空壳中积累,由电化学质子梯度的大小驱动。相反,间羟胺通过非极性脂质相渗透嗜铬颗粒膜,仅根据δpH分布。酪胺的摄取通过两种机制进行。讨论了这些强效生理和药理剂的积累机制对其体内作用的影响。

相似文献

1
Mechanisms of accumulation of tyramine, metaraminol, and isoproterenol in isolated chromaffin granules and ghosts.酪胺、间羟胺和异丙肾上腺素在分离的嗜铬粒和空泡中的蓄积机制。
Biochem Pharmacol. 1982 Mar 1;31(5):815-23. doi: 10.1016/0006-2952(82)90468-3.
2
Biological amine transport in chromaffin ghosts. Coupling to the transmembrane proton and potential gradients.嗜铬细胞空泡中的生物胺转运。与跨膜质子和电位梯度的偶联。
J Biol Chem. 1979 Nov 10;254(21):10963-72.
3
Proton: substrate stoichiometries during active transport of biogenic amines in chromaffin ghosts.质子:嗜铬细胞空泡中生物胺主动转运过程中的底物化学计量学
J Biol Chem. 1981 Jun 10;256(11):5773-80.
4
Protonmotive force and catecholamine transport in isolated chromaffin granules.分离的嗜铬颗粒中的质子动力和儿茶酚胺转运
J Biol Chem. 1979 May 25;254(10):3750-60.
5
A model of biogenic amine accumulation into chromaffin granules and ghosts based on coupling to the electrochemical proton gradient.基于与电化学质子梯度偶联的嗜铬粒蛋白颗粒和空泡中生物胺积累模型。
Fed Proc. 1982 Sep;41(11):2746-54.
6
Role of the proton electrochemical gradient in monoamine transport by bovine chromaffin granules.质子电化学梯度在牛嗜铬颗粒单胺转运中的作用
Biochim Biophys Acta. 1980 Oct 2;601(3):664-77. doi: 10.1016/0005-2736(80)90567-2.
7
Ghosts of chromaffin granules accumulate biogenic amines according to a "pump and leak system" without contribution of carrier-mediated efflux.嗜铬粒蛋白的“幽灵”根据“泵-漏系统”积累生物胺,而不依赖载体介导的流出作用。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Sep;342(3):312-22. doi: 10.1007/BF00169443.
8
Adenosine triphosphate in the bovine chromaffin granule.牛嗜铬颗粒中的三磷酸腺苷
J Physiol (Paris). 1978;74(5):503-8.
9
Mechanisms of proton-linked monoamine transport in chromaffin granule ghosts.嗜铬粒蛋白颗粒膜泡中质子偶联单胺转运的机制
Fed Proc. 1982 Sep;41(11):2742-5.
10
Does the carrier of chromaffin granules transport the protonated or the uncharged species of catecholamines?嗜铬粒蛋白的载体运输的是质子化的儿茶酚胺还是不带电荷的儿茶酚胺物种?
Naunyn Schmiedebergs Arch Pharmacol. 1985 Nov;331(2-3):209-19. doi: 10.1007/BF00634240.

引用本文的文献

1
Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.在大鼠中模拟的人体甲基苯丙胺药代动力学:72小时狂饮的行为和神经化学效应
Neuropsychopharmacology. 2009 Oct;34(11):2430-41. doi: 10.1038/npp.2009.73. Epub 2009 Jul 1.
2
Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.亚甲基二氧甲基苯丙胺与大鼠脑片单胺递质释放机制的相互作用。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Mar;347(3):313-23. doi: 10.1007/BF00167451.
3
Immobilization of rat brain synaptic vesicles on positively-charged glass microspheres.
将大鼠脑突触小泡固定在带正电荷的玻璃微球上。
Experientia. 1983 Jun 15;39(6):623-5. doi: 10.1007/BF01971130.
4
Chemical evidence that catecholamines are transported across the chromaffin granule membrane as noncationic species.儿茶酚胺以非阳离子形式跨嗜铬粒细胞膜转运的化学证据。
Proc Natl Acad Sci U S A. 1983 Apr;80(8):2107-11. doi: 10.1073/pnas.80.8.2107.
5
Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.借助双室模型模拟神经元3H-去甲肾上腺素的外向转运。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):631-40. doi: 10.1007/BF00165753.
6
Veratridine-induced outward transport of 3H-noradrenaline from adrenergic nerves of the rat vas deferens.藜芦碱诱导大鼠输精管肾上腺素能神经释放3H-去甲肾上腺素的外向转运。
Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):621-30. doi: 10.1007/BF00165752.
7
The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: role of monoamine oxidase and of vesicularly stored 3H-noradrenaline.摄取1各种底物的3H-去甲肾上腺素释放效应机制:单胺氧化酶及囊泡储存的3H-去甲肾上腺素的作用
Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):611-20. doi: 10.1007/BF00165751.
8
The mechanism of the 3H-noradrenaline releasing effect of various substrates of uptake1: multifactorial induction of outward transport.摄取1各种底物的3H-去甲肾上腺素释放作用机制:外向转运的多因素诱导
Naunyn Schmiedebergs Arch Pharmacol. 1987 Dec;336(6):602-10. doi: 10.1007/BF00165750.
9
Uptake of norepinephrine and related catecholamines by cultured chromaffin cells: characterization of cocaine-sensitive and -insensitive plasma membrane transport sites.培养的嗜铬细胞对去甲肾上腺素及相关儿茶酚胺的摄取:对可卡因敏感和不敏感的质膜转运位点的特性研究
Proc Natl Acad Sci U S A. 1987 Apr;84(7):1749-53. doi: 10.1073/pnas.84.7.1749.
10
Ghosts of chromaffin granules accumulate biogenic amines according to a "pump and leak system" without contribution of carrier-mediated efflux.嗜铬粒蛋白的“幽灵”根据“泵-漏系统”积累生物胺,而不依赖载体介导的流出作用。
Naunyn Schmiedebergs Arch Pharmacol. 1990 Sep;342(3):312-22. doi: 10.1007/BF00169443.